{
    "title": "Ebola vaccine from Glaxo passes early safety test",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2850972/Ebola-vaccine-Glaxo-passes-early-safety-test.html",
    "date": "2014-11-26",
    "keywords": [
        "vaccine",
        "dose",
        "trial",
        "safety",
        "ebola",
        "response",
        "glaxosmithkline",
        "production",
        "johnson",
        "test",
        "gmt",
        "november",
        "york",
        "side",
        "earlystage",
        "wednesday",
        "journal",
        "medicinethe",
        "sept",
        "hope",
        "profile",
        "finding",
        "lab",
        "anthony",
        "director",
        "institute",
        "allergy",
        "bethesda",
        "marylandthe",
        "niaid",
        "biotechnology",
        "company",
        "material",
        "outbreak",
        "west",
        "africa",
        "sudan",
        "virus",
        "diseasebecause",
        "effectiveness",
        "candidate",
        "immunesystem",
        "half",
        "antiebola",
        "moredose",
        "kind",
        "cell",
        "immunity",
        "bausch",
        "tulane",
        "university",
        "commentary",
        "efficacy",
        "zaire",
        "strain",
        "england",
        "mali",
        "switzerland",
        "newlink",
        "maryland",
        "week",
        "merck",
        "reporting",
        "sharon",
        "begley",
        "editing",
        "jonathan",
        "oatis"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}